Market Cap: $42.05B
RI
Revolution Medicines, Inc.
RVMD
NASDAQ (NASDAQ Global Select)USD
Market Cap: $42.05B
Analysts estimated RVMD earnings of $-2.02 per share this quarter (Q2). RVMD's actual earnings were $-2.34 per share.
RVMD EPS surprise of -16.00%Analysts estimated RVMD earnings of $-1.88 per share this quarter (Q1). RVMD's actual earnings were $-2.29 per share.
RVMD EPS surprise of -22.07%Analysts estimated RVMD earnings of $-1.61 per share this quarter (Q4). RVMD's actual earnings were $-1.86 per share.
RVMD EPS surprise of -15.36%Analysts estimated RVMD earnings of $-1.45 per share this quarter (Q3). RVMD's actual earnings were $-1.61 per share.
RVMD EPS surprise of -11.24%Analysts estimated RVMD earnings of $-1.16 per share this quarter (Q2). RVMD's actual earnings were $-1.31 per share.
RVMD EPS surprise of -12.79%Analysts estimated RVMD earnings of $-1.01 per share this quarter (Q4). RVMD's actual earnings were $-1.12 per share.
RVMD EPS surprise of -11.25%Analysts estimated RVMD earnings of $-0.76 per share this quarter (Q1). RVMD's actual earnings were $-0.70 per share.
RVMD EPS surprise of 8.02%Analysts estimated RVMD earnings of $-0.90 per share this quarter (Q4). RVMD's actual earnings were $-1.14 per share.
RVMD EPS surprise of 26.71%